
|Articles|February 1, 2022
Analytical Quality by Design Based Method Development for the Analysis of Valsartan and Nitrosamines Impurities Using UPLC-MS
Author(s)Waters
In this work, an UltraPerformance Liquid Chromatography method was developed for the analysis of Valsartan and a mixture of six genotoxic impurities using the Analytical Quality by Design (AQbD) approach. Findings indicated that using the AQbD approach and automated software helps gain a deep knowledge about the method and as a result, increases method robustness and reproducibility.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
2
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
3
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
4
Accelerate Your Biologic with HEK Cell Lines
5